Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Yazan Fahmawi, Clayton Smith, Leander Grimm, Shikha Khullar, Paul Rider, John Hunter, Greire Iliff, Wadad Mneimneh, Kelly Roveda, Bin Wang, Pranitha Prodduturvar, Omar Alkharabsheh, Ben McCormick, Meir Mizrahi, Moh'd Khushman

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

In an attempt to identify short-term surrogate endpoints that would predict long-term survival in patients with patients with locally advanced rectal cancer, we explored the usefulness of performing restaging magnetic resonance imaging (MRI). We tested the agreement between restaging MRI T (yT) and N (yN) with ypT and ypN stages, respectively, and explored the prognostic significance of restaging MRI neoadjuvant rectal (NAR) score. Restaging pelvis MRI could not predict ypT or ypN stage. The mean MRI NAR (mNAR) score was higher than the mean NAR score. There was a trend for longer DFS and OS in patients with low-intermediate mNAR score compared to patients with high mNAR scores.

Original languageEnglish
Pages (from-to)e281-e287
JournalClinical Colorectal Cancer
Volume19
Issue number4
DOIs
StatePublished - Dec 2020

Keywords

  • MRI
  • NAR
  • Neoadjuvant rectal score
  • Prognostic significance
  • Surrogate endpoint

Fingerprint

Dive into the research topics of 'Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer'. Together they form a unique fingerprint.

Cite this